nodes	percent_of_prediction	percent_of_DWPC	metapath
Fusidic Acid—ABCB11—Vincristine—lymphatic system cancer	0.434	0.542	CbGbCtD
Fusidic Acid—ABCC2—Vincristine—lymphatic system cancer	0.228	0.285	CbGbCtD
Fusidic Acid—ABCC2—Methotrexate—lymphatic system cancer	0.138	0.173	CbGbCtD
Fusidic Acid—Vasospasm—Carmustine—lymphatic system cancer	0.00637	0.0321	CcSEcCtD
Fusidic Acid—Periorbital oedema—Bleomycin—lymphatic system cancer	0.00631	0.0317	CcSEcCtD
Fusidic Acid—Thrombophlebitis—Mechlorethamine—lymphatic system cancer	0.0044	0.0221	CcSEcCtD
Fusidic Acid—Epigastric pain—Mitoxantrone—lymphatic system cancer	0.00419	0.0211	CcSEcCtD
Fusidic Acid—Burning sensation—Carmustine—lymphatic system cancer	0.00313	0.0158	CcSEcCtD
Fusidic Acid—Pancytopenia—Mechlorethamine—lymphatic system cancer	0.00313	0.0157	CcSEcCtD
Fusidic Acid—Reaction gastrointestinal—Methotrexate—lymphatic system cancer	0.00302	0.0152	CcSEcCtD
Fusidic Acid—Jaundice—Mechlorethamine—lymphatic system cancer	0.00286	0.0144	CcSEcCtD
Fusidic Acid—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.00274	0.0138	CcSEcCtD
Fusidic Acid—Drug interaction—Carmustine—lymphatic system cancer	0.00235	0.0118	CcSEcCtD
Fusidic Acid—Pancytopenia—Teniposide—lymphatic system cancer	0.00231	0.0116	CcSEcCtD
Fusidic Acid—Neutropenia—Teniposide—lymphatic system cancer	0.00227	0.0114	CcSEcCtD
Fusidic Acid—Drug interaction—Vincristine—lymphatic system cancer	0.00224	0.0113	CcSEcCtD
Fusidic Acid—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00205	0.0103	CcSEcCtD
Fusidic Acid—Pancytopenia—Fludarabine—lymphatic system cancer	0.00203	0.0102	CcSEcCtD
Fusidic Acid—Neutropenia—Fludarabine—lymphatic system cancer	0.002	0.01	CcSEcCtD
Fusidic Acid—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.00194	0.00976	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00183	0.00922	CcSEcCtD
Fusidic Acid—Thrombophlebitis—Carmustine—lymphatic system cancer	0.00183	0.00918	CcSEcCtD
Fusidic Acid—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00182	0.00915	CcSEcCtD
Fusidic Acid—Swelling—Carmustine—lymphatic system cancer	0.00179	0.00901	CcSEcCtD
Fusidic Acid—Anorexia—Mechlorethamine—lymphatic system cancer	0.00179	0.00898	CcSEcCtD
Fusidic Acid—Eye pain—Carmustine—lymphatic system cancer	0.00175	0.0088	CcSEcCtD
Fusidic Acid—Arrhythmia—Teniposide—lymphatic system cancer	0.00174	0.00873	CcSEcCtD
Fusidic Acid—Swelling—Mitoxantrone—lymphatic system cancer	0.00167	0.00838	CcSEcCtD
Fusidic Acid—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00163	0.00819	CcSEcCtD
Fusidic Acid—Renal failure acute—Mitoxantrone—lymphatic system cancer	0.00159	0.008	CcSEcCtD
Fusidic Acid—Anaemia—Teniposide—lymphatic system cancer	0.00156	0.00787	CcSEcCtD
Fusidic Acid—Arrhythmia—Fludarabine—lymphatic system cancer	0.00153	0.00768	CcSEcCtD
Fusidic Acid—Leukopenia—Teniposide—lymphatic system cancer	0.00151	0.00762	CcSEcCtD
Fusidic Acid—Pancytopenia—Bleomycin—lymphatic system cancer	0.00149	0.00747	CcSEcCtD
Fusidic Acid—Burning sensation—Methotrexate—lymphatic system cancer	0.00145	0.0073	CcSEcCtD
Fusidic Acid—Muscular weakness—Carmustine—lymphatic system cancer	0.00139	0.00701	CcSEcCtD
Fusidic Acid—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00138	0.00694	CcSEcCtD
Fusidic Acid—Anaemia—Fludarabine—lymphatic system cancer	0.00137	0.00691	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00135	0.0068	CcSEcCtD
Fusidic Acid—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.00134	0.00675	CcSEcCtD
Fusidic Acid—Leukopenia—Fludarabine—lymphatic system cancer	0.00133	0.0067	CcSEcCtD
Fusidic Acid—Muscular weakness—Vincristine—lymphatic system cancer	0.00133	0.00669	CcSEcCtD
Fusidic Acid—Pruritus—Mechlorethamine—lymphatic system cancer	0.00133	0.00667	CcSEcCtD
Fusidic Acid—Anorexia—Teniposide—lymphatic system cancer	0.00132	0.00662	CcSEcCtD
Fusidic Acid—Pancytopenia—Carmustine—lymphatic system cancer	0.0013	0.00652	CcSEcCtD
Fusidic Acid—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00128	0.00645	CcSEcCtD
Fusidic Acid—Neutropenia—Carmustine—lymphatic system cancer	0.00128	0.00642	CcSEcCtD
Fusidic Acid—Discomfort—Fludarabine—lymphatic system cancer	0.00125	0.00629	CcSEcCtD
Fusidic Acid—Pancytopenia—Vincristine—lymphatic system cancer	0.00124	0.00623	CcSEcCtD
Fusidic Acid—Neutropenia—Vincristine—lymphatic system cancer	0.00122	0.00613	CcSEcCtD
Fusidic Acid—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00121	0.00607	CcSEcCtD
Fusidic Acid—Decreased appetite—Teniposide—lymphatic system cancer	0.0012	0.00604	CcSEcCtD
Fusidic Acid—Vomiting—Mechlorethamine—lymphatic system cancer	0.00119	0.00599	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00119	0.00598	CcSEcCtD
Fusidic Acid—Neutropenia—Mitoxantrone—lymphatic system cancer	0.00119	0.00597	CcSEcCtD
Fusidic Acid—Rash—Mechlorethamine—lymphatic system cancer	0.00118	0.00594	CcSEcCtD
Fusidic Acid—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00118	0.00593	CcSEcCtD
Fusidic Acid—Anorexia—Fludarabine—lymphatic system cancer	0.00116	0.00582	CcSEcCtD
Fusidic Acid—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00113	0.00568	CcSEcCtD
Fusidic Acid—Bone disorder—Methotrexate—lymphatic system cancer	0.00112	0.00562	CcSEcCtD
Fusidic Acid—Nausea—Mechlorethamine—lymphatic system cancer	0.00111	0.0056	CcSEcCtD
Fusidic Acid—Jaundice—Mitoxantrone—lymphatic system cancer	0.0011	0.00555	CcSEcCtD
Fusidic Acid—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.0011	0.00554	CcSEcCtD
Fusidic Acid—Urticaria—Teniposide—lymphatic system cancer	0.0011	0.00552	CcSEcCtD
Fusidic Acid—Abdominal pain—Teniposide—lymphatic system cancer	0.00109	0.00549	CcSEcCtD
Fusidic Acid—Erythema—Bleomycin—lymphatic system cancer	0.00109	0.00548	CcSEcCtD
Fusidic Acid—Dyspepsia—Fludarabine—lymphatic system cancer	0.00107	0.00537	CcSEcCtD
Fusidic Acid—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00106	0.00531	CcSEcCtD
Fusidic Acid—Decreased appetite—Fludarabine—lymphatic system cancer	0.00106	0.00531	CcSEcCtD
Fusidic Acid—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00105	0.00527	CcSEcCtD
Fusidic Acid—Inflammation—Methotrexate—lymphatic system cancer	0.00104	0.00523	CcSEcCtD
Fusidic Acid—Pain—Fludarabine—lymphatic system cancer	0.00104	0.00522	CcSEcCtD
Fusidic Acid—Eye disorder—Carmustine—lymphatic system cancer	0.00102	0.00514	CcSEcCtD
Fusidic Acid—Hypersensitivity—Teniposide—lymphatic system cancer	0.00102	0.00512	CcSEcCtD
Fusidic Acid—Anaemia—Bleomycin—lymphatic system cancer	0.00101	0.00507	CcSEcCtD
Fusidic Acid—Pruritus—Teniposide—lymphatic system cancer	0.000977	0.00491	CcSEcCtD
Fusidic Acid—Arrhythmia—Carmustine—lymphatic system cancer	0.000977	0.00491	CcSEcCtD
Fusidic Acid—Leukopenia—Bleomycin—lymphatic system cancer	0.000976	0.00491	CcSEcCtD
Fusidic Acid—Erythema—Carmustine—lymphatic system cancer	0.000952	0.00479	CcSEcCtD
Fusidic Acid—Diarrhoea—Teniposide—lymphatic system cancer	0.000945	0.00475	CcSEcCtD
Fusidic Acid—Discomfort—Bleomycin—lymphatic system cancer	0.000917	0.00461	CcSEcCtD
Fusidic Acid—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000908	0.00457	CcSEcCtD
Fusidic Acid—Vision blurred—Carmustine—lymphatic system cancer	0.000897	0.00451	CcSEcCtD
Fusidic Acid—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000894	0.0045	CcSEcCtD
Fusidic Acid—Erythema—Mitoxantrone—lymphatic system cancer	0.000885	0.00445	CcSEcCtD
Fusidic Acid—Anaemia—Carmustine—lymphatic system cancer	0.00088	0.00442	CcSEcCtD
Fusidic Acid—Vomiting—Teniposide—lymphatic system cancer	0.000878	0.00442	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000871	0.00438	CcSEcCtD
Fusidic Acid—Rash—Teniposide—lymphatic system cancer	0.000871	0.00438	CcSEcCtD
Fusidic Acid—Dermatitis—Teniposide—lymphatic system cancer	0.00087	0.00438	CcSEcCtD
Fusidic Acid—Headache—Teniposide—lymphatic system cancer	0.000865	0.00435	CcSEcCtD
Fusidic Acid—Pruritus—Fludarabine—lymphatic system cancer	0.000859	0.00432	CcSEcCtD
Fusidic Acid—Leukopenia—Carmustine—lymphatic system cancer	0.000852	0.00428	CcSEcCtD
Fusidic Acid—Anorexia—Bleomycin—lymphatic system cancer	0.000848	0.00427	CcSEcCtD
Fusidic Acid—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000846	0.00425	CcSEcCtD
Fusidic Acid—Anaemia—Vincristine—lymphatic system cancer	0.00084	0.00422	CcSEcCtD
Fusidic Acid—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000834	0.00419	CcSEcCtD
Fusidic Acid—Diarrhoea—Fludarabine—lymphatic system cancer	0.00083	0.00418	CcSEcCtD
Fusidic Acid—Nausea—Teniposide—lymphatic system cancer	0.00082	0.00413	CcSEcCtD
Fusidic Acid—Anaemia—Mitoxantrone—lymphatic system cancer	0.000818	0.00411	CcSEcCtD
Fusidic Acid—Leukopenia—Vincristine—lymphatic system cancer	0.000813	0.00409	CcSEcCtD
Fusidic Acid—Renal failure acute—Methotrexate—lymphatic system cancer	0.000793	0.00399	CcSEcCtD
Fusidic Acid—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000792	0.00398	CcSEcCtD
Fusidic Acid—Decreased appetite—Bleomycin—lymphatic system cancer	0.000774	0.00389	CcSEcCtD
Fusidic Acid—Vomiting—Fludarabine—lymphatic system cancer	0.000772	0.00388	CcSEcCtD
Fusidic Acid—Rash—Fludarabine—lymphatic system cancer	0.000765	0.00385	CcSEcCtD
Fusidic Acid—Dermatitis—Fludarabine—lymphatic system cancer	0.000765	0.00385	CcSEcCtD
Fusidic Acid—Pain—Bleomycin—lymphatic system cancer	0.000761	0.00383	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000761	0.00383	CcSEcCtD
Fusidic Acid—Headache—Fludarabine—lymphatic system cancer	0.00076	0.00382	CcSEcCtD
Fusidic Acid—Lethargy—Methotrexate—lymphatic system cancer	0.000747	0.00376	CcSEcCtD
Fusidic Acid—Discomfort—Mitoxantrone—lymphatic system cancer	0.000744	0.00374	CcSEcCtD
Fusidic Acid—Anorexia—Carmustine—lymphatic system cancer	0.00074	0.00372	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000726	0.00365	CcSEcCtD
Fusidic Acid—Nausea—Fludarabine—lymphatic system cancer	0.000721	0.00363	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000707	0.00356	CcSEcCtD
Fusidic Acid—Urticaria—Bleomycin—lymphatic system cancer	0.000707	0.00356	CcSEcCtD
Fusidic Acid—Anorexia—Vincristine—lymphatic system cancer	0.000707	0.00355	CcSEcCtD
Fusidic Acid—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000701	0.00353	CcSEcCtD
Fusidic Acid—Anorexia—Mitoxantrone—lymphatic system cancer	0.000688	0.00346	CcSEcCtD
Fusidic Acid—Decreased appetite—Carmustine—lymphatic system cancer	0.000675	0.0034	CcSEcCtD
Fusidic Acid—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000671	0.00337	CcSEcCtD
Fusidic Acid—Pain—Carmustine—lymphatic system cancer	0.000664	0.00334	CcSEcCtD
Fusidic Acid—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000656	0.0033	CcSEcCtD
Fusidic Acid—Decreased appetite—Vincristine—lymphatic system cancer	0.000645	0.00324	CcSEcCtD
Fusidic Acid—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00064	0.00322	CcSEcCtD
Fusidic Acid—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000636	0.0032	CcSEcCtD
Fusidic Acid—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000635	0.00319	CcSEcCtD
Fusidic Acid—Pain—Vincristine—lymphatic system cancer	0.000634	0.00319	CcSEcCtD
Fusidic Acid—Pruritus—Bleomycin—lymphatic system cancer	0.00063	0.00317	CcSEcCtD
Fusidic Acid—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000628	0.00316	CcSEcCtD
Fusidic Acid—Pain—Mitoxantrone—lymphatic system cancer	0.000618	0.00311	CcSEcCtD
Fusidic Acid—Abdominal pain—Carmustine—lymphatic system cancer	0.000614	0.00309	CcSEcCtD
Fusidic Acid—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000606	0.00305	CcSEcCtD
Fusidic Acid—Pancytopenia—Methotrexate—lymphatic system cancer	0.000601	0.00302	CcSEcCtD
Fusidic Acid—Neutropenia—Methotrexate—lymphatic system cancer	0.000592	0.00298	CcSEcCtD
Fusidic Acid—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000591	0.00297	CcSEcCtD
Fusidic Acid—Abdominal pain—Vincristine—lymphatic system cancer	0.000586	0.00295	CcSEcCtD
Fusidic Acid—Urticaria—Mitoxantrone—lymphatic system cancer	0.000574	0.00289	CcSEcCtD
Fusidic Acid—Hypersensitivity—Carmustine—lymphatic system cancer	0.000572	0.00288	CcSEcCtD
Fusidic Acid—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000571	0.00287	CcSEcCtD
Fusidic Acid—Vomiting—Bleomycin—lymphatic system cancer	0.000566	0.00285	CcSEcCtD
Fusidic Acid—Rash—Bleomycin—lymphatic system cancer	0.000561	0.00282	CcSEcCtD
Fusidic Acid—Dermatitis—Bleomycin—lymphatic system cancer	0.000561	0.00282	CcSEcCtD
Fusidic Acid—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000548	0.00276	CcSEcCtD
Fusidic Acid—Hypersensitivity—Vincristine—lymphatic system cancer	0.000546	0.00275	CcSEcCtD
Fusidic Acid—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000534	0.00268	CcSEcCtD
Fusidic Acid—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000532	0.00268	CcSEcCtD
Fusidic Acid—Diarrhoea—Carmustine—lymphatic system cancer	0.000531	0.00267	CcSEcCtD
Fusidic Acid—Nausea—Bleomycin—lymphatic system cancer	0.000529	0.00266	CcSEcCtD
Fusidic Acid—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000526	0.00265	CcSEcCtD
Fusidic Acid—Dizziness—Carmustine—lymphatic system cancer	0.000514	0.00258	CcSEcCtD
Fusidic Acid—Diarrhoea—Vincristine—lymphatic system cancer	0.000507	0.00255	CcSEcCtD
Fusidic Acid—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000494	0.00249	CcSEcCtD
Fusidic Acid—Vomiting—Carmustine—lymphatic system cancer	0.000494	0.00248	CcSEcCtD
Fusidic Acid—Dizziness—Vincristine—lymphatic system cancer	0.00049	0.00247	CcSEcCtD
Fusidic Acid—Rash—Carmustine—lymphatic system cancer	0.00049	0.00246	CcSEcCtD
Fusidic Acid—Dermatitis—Carmustine—lymphatic system cancer	0.000489	0.00246	CcSEcCtD
Fusidic Acid—Headache—Carmustine—lymphatic system cancer	0.000487	0.00245	CcSEcCtD
Fusidic Acid—Eye disorder—Methotrexate—lymphatic system cancer	0.000473	0.00238	CcSEcCtD
Fusidic Acid—Vomiting—Vincristine—lymphatic system cancer	0.000471	0.00237	CcSEcCtD
Fusidic Acid—Rash—Vincristine—lymphatic system cancer	0.000468	0.00235	CcSEcCtD
Fusidic Acid—Dermatitis—Vincristine—lymphatic system cancer	0.000467	0.00235	CcSEcCtD
Fusidic Acid—Headache—Vincristine—lymphatic system cancer	0.000465	0.00234	CcSEcCtD
Fusidic Acid—Nausea—Carmustine—lymphatic system cancer	0.000461	0.00232	CcSEcCtD
Fusidic Acid—Vomiting—Mitoxantrone—lymphatic system cancer	0.000459	0.00231	CcSEcCtD
Fusidic Acid—Immune system disorder—Methotrexate—lymphatic system cancer	0.000457	0.0023	CcSEcCtD
Fusidic Acid—Rash—Mitoxantrone—lymphatic system cancer	0.000455	0.00229	CcSEcCtD
Fusidic Acid—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000455	0.00229	CcSEcCtD
Fusidic Acid—Headache—Mitoxantrone—lymphatic system cancer	0.000452	0.00228	CcSEcCtD
Fusidic Acid—Erythema—Methotrexate—lymphatic system cancer	0.000441	0.00222	CcSEcCtD
Fusidic Acid—Nausea—Vincristine—lymphatic system cancer	0.00044	0.00222	CcSEcCtD
Fusidic Acid—Nausea—Mitoxantrone—lymphatic system cancer	0.000429	0.00216	CcSEcCtD
Fusidic Acid—Vision blurred—Methotrexate—lymphatic system cancer	0.000415	0.00209	CcSEcCtD
Fusidic Acid—Anaemia—Methotrexate—lymphatic system cancer	0.000407	0.00205	CcSEcCtD
Fusidic Acid—Leukopenia—Methotrexate—lymphatic system cancer	0.000395	0.00198	CcSEcCtD
Fusidic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000373	0.00187	CcSEcCtD
Fusidic Acid—Discomfort—Methotrexate—lymphatic system cancer	0.000371	0.00187	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000352	0.00177	CcSEcCtD
Fusidic Acid—Skin disorder—Methotrexate—lymphatic system cancer	0.000349	0.00176	CcSEcCtD
Fusidic Acid—Anorexia—Methotrexate—lymphatic system cancer	0.000343	0.00172	CcSEcCtD
Fusidic Acid—Dyspepsia—Methotrexate—lymphatic system cancer	0.000317	0.00159	CcSEcCtD
Fusidic Acid—Decreased appetite—Methotrexate—lymphatic system cancer	0.000313	0.00157	CcSEcCtD
Fusidic Acid—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000311	0.00156	CcSEcCtD
Fusidic Acid—Pain—Methotrexate—lymphatic system cancer	0.000308	0.00155	CcSEcCtD
Fusidic Acid—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000294	0.00148	CcSEcCtD
Fusidic Acid—Urticaria—Methotrexate—lymphatic system cancer	0.000286	0.00144	CcSEcCtD
Fusidic Acid—Abdominal pain—Methotrexate—lymphatic system cancer	0.000284	0.00143	CcSEcCtD
Fusidic Acid—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000265	0.00133	CcSEcCtD
Fusidic Acid—Pruritus—Methotrexate—lymphatic system cancer	0.000255	0.00128	CcSEcCtD
Fusidic Acid—Diarrhoea—Methotrexate—lymphatic system cancer	0.000246	0.00124	CcSEcCtD
Fusidic Acid—Dizziness—Methotrexate—lymphatic system cancer	0.000238	0.0012	CcSEcCtD
Fusidic Acid—Vomiting—Methotrexate—lymphatic system cancer	0.000229	0.00115	CcSEcCtD
Fusidic Acid—Rash—Methotrexate—lymphatic system cancer	0.000227	0.00114	CcSEcCtD
Fusidic Acid—Dermatitis—Methotrexate—lymphatic system cancer	0.000227	0.00114	CcSEcCtD
Fusidic Acid—Headache—Methotrexate—lymphatic system cancer	0.000225	0.00113	CcSEcCtD
Fusidic Acid—Nausea—Methotrexate—lymphatic system cancer	0.000214	0.00107	CcSEcCtD
